KEGG   DRUG: Zagotenemab
Entry
D11533                      Drug                                   
Name
Zagotenemab (USAN)
Formula
C6448H9976N1712O2026S44
Exact mass
145215.7934
Mol weight
145305.3178
Sequence
(Heqvy chain)
EVQLVQSGAE VKKPGESLKI SCKGSGYTFS NYWIEWVRQM PGKGLEWMGE ILPGSDSIKY
EKNFKGQVTI SADKSISTAY LQWSSLKASD TAMYYCARRG NYVDDWGQGT LVTVSSASTK
GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEA AGGPSVFLFP
PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS
VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS
LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS
CSVMHEALHN HYTQKSLSLS LG
(Light chain)
EIVLTQSPGT LSLSPGERAT LSCRSSQSLV HSNQNTYLHW YQQKPGQAPR LLIYKVDNRF
SGIPDRFSGS GSGTDFTLTI SRLEPEDFAV YYCSQSTLVP LTFGGGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H130-L219, H143-H199, H222-H'222, H225-H'225, H257-H317, H363-H421, H'22-H'96, H'130-L'219, H'143-H'199, H'257-H'317, H'363-H'421, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Anti-tau protein antibody
  Type
Monoclonal antibody
Comment
Treatment of Alzheimer's disease and other tauopathies
Target
MAPT (TAU) [HSA:4137] [KO:K04380]
  Pathway
hsa04010  MAPK signaling pathway
hsa05010  Alzheimer disease
hsa05022  Pathways of neurodegeneration - multiple diseases
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    MAPT (TAU)
     D11533  Zagotenemab (USAN)
Other DBs
CAS: 2019133-28-7
PubChem: 384585509
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system